Skip to content
healthcare.dev

Lamotrigine

NDC 46708-418, Lamotrigine, tablet, extended release, from Alembic Pharmaceuticals Limited.

Product NDC
46708-418
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211821
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-418 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE250 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
46708-418-304670804183030 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-418-30)
46708-418-91467080418911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-418-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/faee013c-cad2-4abb-904c-e6ff79ba778c

Use it

Look up 46708-418 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-418 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-418. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.